job ratings (see below graph) for Biotech

05/15/25
industry:
Biotech
job title:
Sr Scientist
company:
job rating:
1 - I hate my job
Having two drugs on the top of the most expensive drugs list is a shame. It is clear that insurance companies increase premiums to all others for select few treated. Time to leave Sarepta.
05/03/25
industry:
Biotech
company:
job rating:
3
Pharma companies disguise themselves as gentle and caring lambs working hard to save lives. The scale of money involved in rare diseases cure is disproportional to resulting benefits. This is a cover up for industrial elites to live a safe and wealthy existence, whereas their technology lags behind and development progress is much slower than in other industries. Increasingly the work is offshored and the pharma companies mostly add to the cost being the wealth-consuming part in the chain. In contrast to rare diseases and gene and cell therapy that may be focused on small numbers of patients, vaccines are directed towards large populations and must be developed quickly. Being from vaccine field we have little respect for people who doodle for years to develop some marginal drugs and getting rich in the process
04/25/25
industry:
Biotech
job title:
tech
company:
job rating:
1 - I hate my job
bosss
01/19/25
industry:
Biotech
job rating:
1 - I hate my job
At last JPM Conference in SF the wonderful management team demonstrated how they will rune the company. To the ground.
01/19/25
industry:
Biotech
company:
job rating:
1 - I hate my job
2025 Davos is coming. The company is also enamored with Global Lighthouse Network by World Economic Forum. We know what that Forum represents. USA has DeepState. WEF is DeepGlobalism.
01/17/25
industry:
Biotech
company:
job rating:
2
Interesting how Amgen is going to adjust to policies of new administration and how this would affect jobs?
01/15/25
industry:
Biotech
company:
job rating:
1 - I hate my job
At JPM Conf. Biomarin presentation did not convince investors and stock has tanked. Interesting that CEO brought his new set of upper management and only Brian from the old set. This shows that old management is on its way out as someone indicated on this site. Would such replacement help the company? New management may not understand specifics of future portfolio. Or they are there to complete M&A deal.
01/09/25
industry:
Biotech
company:
job rating:
1 - I hate my job
Layoffs! Cell therapy in question. Gilead is in retreat, so how about Kite? Cell therapy is like a laboratory and clinical procedure development, not a typical pharma drug development. Often at enormous cost. And a market size and economics?
12/22/24
industry:
Biotech
company:
job rating:
1 - I hate my job
Genentech under Roche is diminishing continually. Manufacturing related jobs are practically only in Oregon. There are fewer opportunities in R&D in SSF. Wonder what is going to be shut down next. Layoffs are probable in 2025.
11/09/24
industry:
Biotech
job rating:
1 - I hate my job
Comment to Biomarin post: Time to publish the names of managers who throw their team members under the bus during layoffs

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.